| scholarly article | Q13442814 |
| P50 | author | G-One Ahn | Q89392327 |
| P2093 | author name string | J Martin Brown | |
| P2860 | cites work | Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis | Q24610450 |
| Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth | Q28203327 | ||
| Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 | ||
| Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations | Q29544430 | ||
| Distinct role of macrophages in different tumor microenvironments | Q29614304 | ||
| Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas | Q58212133 | ||
| Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia | Q58816235 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type | Q69989389 | ||
| Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing | Q72115839 | ||
| Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium | Q74253951 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy | Q79312562 | ||
| Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer | Q79404723 | ||
| VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells | Q82264553 | ||
| Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis | Q83290621 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease | Q29619726 | ||
| MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis | Q33744153 | ||
| Extrinsic regulators of epithelial tumor progression: metalloproteinases | Q33840437 | ||
| Regulation of HIF-1alpha stability through S-nitrosylation | Q34001616 | ||
| Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases | Q34176489 | ||
| Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules | Q34320910 | ||
| Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 | ||
| Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production | Q34556431 | ||
| Macrophages regulate the angiogenic switch in a mouse model of breast cancer | Q34582812 | ||
| Targeting tumor-associated macrophages as a novel strategy against breast cancer | Q34803221 | ||
| Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? | Q34988256 | ||
| Myeloid lineage progenitors give rise to vascular endothelium. | Q35016546 | ||
| Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice | Q36077023 | ||
| Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy | Q36414978 | ||
| Monocyte/macrophage infiltration in tumors: modulators of angiogenesis | Q36602360 | ||
| Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach | Q36612202 | ||
| The multifaceted circulating endothelial cell in cancer: towards marker and target identification. | Q36621435 | ||
| An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. | Q37486791 | ||
| Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. | Q40100311 | ||
| Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. | Q40151555 | ||
| Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. | Q40228810 | ||
| Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion | Q40353398 | ||
| The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. | Q40434427 | ||
| Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice | Q41902466 | ||
| The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis | Q42411644 | ||
| Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells | Q42451021 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques | Q42612056 | ||
| G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism | Q42742048 | ||
| A new mouse tumor model system (RIF-1) for comparison of end-point studies | Q42799818 | ||
| Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. | Q43540226 | ||
| Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy | Q43870174 | ||
| Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors | Q44636591 | ||
| Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. | Q44928916 | ||
| Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells | Q45862226 | ||
| The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding. | Q45962049 | ||
| The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products | Q46395684 | ||
| Blood monocytes mimic endothelial progenitor cells | Q46686010 | ||
| Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. | Q50695105 | ||
| Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. | Q51786158 | ||
| Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. | Q54013783 | ||
| P433 | issue | 3 | |
| P921 | main subject | angiogenesis | Q539568 |
| bone marrow | Q546523 | ||
| vasculogenesis | Q1424593 | ||
| P304 | page(s) | 193-205 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells | |
| P478 | volume | 13 |
| Q34328033 | A bioinformatics filtering strategy for identifying radiation response biomarker candidates |
| Q42413251 | A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization |
| Q34870640 | A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. |
| Q39193551 | A preclinical study to explore vasculature differences between primary and recurrent tumors using ultrasound Doppler imaging. |
| Q52714962 | Abemaciclib, a Selective CDK4/6 Inhibitor Enhances the Radiosensitivity of Non-Small Cell Lung Cancer in vitro and in vivo. |
| Q35958252 | Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions |
| Q37672893 | Altered macrophage phenotype transition impairs skeletal muscle regeneration |
| Q90353123 | An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? |
| Q30559417 | Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. |
| Q37951606 | Antiangiogenic effects of zoledronate on cancer neovasculature |
| Q33638344 | Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment |
| Q38806270 | Antitumorigenic targets of cannabinoids - current status and implications |
| Q38818713 | Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects |
| Q28288148 | Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade |
| Q37409716 | Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats |
| Q36390700 | Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks |
| Q34369895 | Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors |
| Q34520820 | Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9 |
| Q58734172 | Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF) |
| Q53287381 | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. |
| Q34518337 | CXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer Growth |
| Q37769017 | Cancer-associated myeloproliferation: old association, new therapeutic target |
| Q22242922 | Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability |
| Q35093740 | Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy |
| Q37739010 | Cell-based methods for ex vivo evaluation of human endothelial biology. |
| Q45056870 | Cerebrovascular Remodeling and Neuroinflammation is a Late Effect of Radiation-Induced Brain Injury in Non-Human Primates |
| Q46104713 | Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors |
| Q38800593 | Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments |
| Q44050700 | Class A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and mice |
| Q30930526 | Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors |
| Q35043560 | Clinical significance of sIL-2R levels in B-cell lymphomas |
| Q39388167 | Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma |
| Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
| Q34582640 | Combinations of immunotherapy and radiation in cancer therapy. |
| Q35645125 | Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth |
| Q37148144 | Combined hyperthermia and radiotherapy for the treatment of cancer |
| Q60939646 | Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity? |
| Q36079807 | Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments |
| Q37028696 | Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. |
| Q28576485 | Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo |
| Q36278280 | Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. |
| Q57144581 | DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival |
| Q39456092 | Delta-like ligand 4-notch blockade and tumor radiation response |
| Q35766758 | Dequalinium blocks macrophage-induced metastasis following local radiation |
| Q37978661 | Dermal mast cells affect the development of sunlight-induced skin tumours. |
| Q37594031 | Different but synergistic effects of bone marrow-derived VEGFR2+ and VEGFR2-CD45+ cells during hepatocellular carcinoma progression |
| Q34578277 | Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. |
| Q41961732 | Dual role of the leukocyte integrin αMβ2 in angiogenesis |
| Q55304879 | Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer. |
| Q35926659 | Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma |
| Q27345020 | Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis. |
| Q33767975 | Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection |
| Q38983908 | Effects of pre-irradiation and SDF-1 suppression on the progression of murine astrocytoma cells grown in different stromal beds. |
| Q37694918 | Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors |
| Q38869603 | Emerging targets for radioprotection and radiosensitization in radiotherapy |
| Q33873312 | Endothelium originated from colorectal cancer stem cells constitute cancer blood vessels |
| Q30408302 | Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors |
| Q37593466 | Enhancing the efficacy of cancer vaccines in urologic oncology: new directions |
| Q64891812 | Gastric carcinogenesis. |
| Q24568374 | Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression |
| Q88450845 | Gene Expression Profiles in Chemokine (C-C Motif) Ligand 21-Overexpressing Pancreatic Cancer Cells |
| Q44671365 | Gene expression changes after ionizing radiation in endothelial cells derived from human endometrial cancer-preliminary outcomes |
| Q39030742 | Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation |
| Q34354547 | Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences |
| Q43009524 | Henry S. Kaplan Distinguished Scientist Award Lecture 2007. The remarkable yin and yang of tumour hypoxia |
| Q24606366 | Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche |
| Q38332863 | Identification of high-risk human papillomavirus (hrHPV)-associated genes in early stage cervical squamous cell carcinomas |
| Q37246401 | Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer |
| Q83575417 | Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis |
| Q36337310 | Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review |
| Q26767150 | Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis |
| Q33822929 | Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives |
| Q38135118 | Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy |
| Q37632115 | Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. |
| Q33929607 | Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment |
| Q37057231 | Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases |
| Q33915046 | Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth |
| Q28274091 | Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q34469812 | Ionizing radiation induces tumor cell lysyl oxidase secretion |
| Q36142366 | Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. |
| Q42684094 | Is vasculogenesis crucial for the regrowth of irradiated tumours? |
| Q24598701 | Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9) |
| Q44243239 | Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma. |
| Q53090556 | Loss of stromal JUNB does not affect tumor growth and angiogenesis. |
| Q64241048 | MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation |
| Q37189109 | MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation |
| Q54362749 | MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis. |
| Q35086941 | MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury. |
| Q42364151 | MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma |
| Q27853354 | MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study. |
| Q33570512 | MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer |
| Q35025845 | MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis |
| Q92178524 | Markers of Cancer Cell Invasion: Are They Good Enough? |
| Q35043525 | Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. |
| Q35892721 | Matrix metalloproteinases as breast cancer drivers and therapeutic targets |
| Q33732496 | Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q29619858 | Matrix metalloproteinases: regulators of the tumor microenvironment |
| Q35720752 | Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K. |
| Q38196881 | Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications |
| Q92995794 | Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1 |
| Q37617724 | Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? |
| Q34948795 | Molecular mechanisms involved in tumor repopulation after radiotherapy |
| Q37729131 | Molecular pathways and targets in cancer-related inflammation |
| Q84744195 | Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model |
| Q38613648 | Myeloid Derived Suppressor Cells: Fuel the Fire |
| Q27014189 | Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications |
| Q36047741 | Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors? |
| Q30490801 | Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. |
| Q36943936 | Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma |
| Q51802063 | Neutrophils, a candidate biomarker and target for radiation therapy? |
| Q37981959 | New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis |
| Q36983730 | Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance. |
| Q64075507 | Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy |
| Q92099132 | Obstructive sleep apnea syndrome promotes the progression of aortic dissection via a ROS- HIF-1α-MMPs associated pathway |
| Q42477969 | Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis |
| Q39011826 | One microenvironment does not fit all: heterogeneity beyond cancer cells |
| Q99579151 | Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment |
| Q36982546 | Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. |
| Q37338567 | Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth |
| Q38588910 | Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer |
| Q41413177 | Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells |
| Q33665623 | Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions |
| Q38743711 | Pre-metastatic niches: organ-specific homes for metastases. |
| Q35745103 | Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer |
| Q53104093 | Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. |
| Q53387643 | Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. |
| Q34408248 | RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis |
| Q40508998 | Rab27a regulates GM-CSF-dependent priming of neutrophil exocytosis. |
| Q47703452 | Radiation effects on antitumor immune responses: current perspectives and challenges |
| Q28080006 | Radiation-induced immune responses: mechanisms and therapeutic perspectives |
| Q39434440 | Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies |
| Q27022685 | Radiotherapy and the tumor stroma: the importance of dose and fractionation |
| Q33605773 | Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting |
| Q38199128 | Recent advances and future trends in the targeted therapy of metastatic gastric cancer |
| Q40978947 | Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody |
| Q34052833 | Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation |
| Q35793888 | Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway |
| Q35083186 | Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy |
| Q51026487 | Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. |
| Q30476541 | Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer |
| Q28559652 | Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors |
| Q34381246 | Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance |
| Q33685705 | Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas |
| Q33824295 | Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature |
| Q37373047 | Role of leukemia cell invadosome in extramedullary infiltration |
| Q35603122 | Roles of bone marrow cells in skeletal metastases: no longer bystanders |
| Q37491439 | SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI. |
| Q36860502 | Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas |
| Q51392451 | Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. |
| Q27306938 | Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer |
| Q43754838 | Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients? |
| Q28080262 | Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy |
| Q35551808 | Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration |
| Q96430962 | Snail promotes the generation of vascular endothelium by breast cancer cells |
| Q38953409 | Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation |
| Q37806811 | Stem cells in tumor angiogenesis |
| Q37531724 | Strategies for optimizing the response of cancer and normal tissues to radiation |
| Q38015229 | Strategies for the discovery and development of therapies for metastatic breast cancer |
| Q37856721 | Strategies to improve radiotherapy with targeted drugs |
| Q28749398 | Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cells |
| Q55518188 | Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer. |
| Q37539309 | Systemic effects of local radiotherapy |
| Q55429319 | TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. |
| Q24606406 | TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice |
| Q37876686 | Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas |
| Q34082067 | Targeting immune suppressing myeloid-derived suppressor cells in oncology. |
| Q93129559 | Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs |
| Q64063956 | Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives |
| Q64071654 | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy |
| Q37767356 | Targeting the tumour vasculature: insights from physiological angiogenesis |
| Q37625320 | The Prognostic Value of Baseline Lymphocyte, Neutrophil, and Monocyte Counts in Locally Advanced Cervical Carcinoma Treated with Radiation |
| Q92541856 | The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma |
| Q38877313 | The Promise of Targeting Macrophages in Cancer Therapy |
| Q26775269 | The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis |
| Q85317146 | The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age |
| Q37987661 | The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities |
| Q37374031 | The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? |
| Q38091871 | The host immunological response to cancer therapy: An emerging concept in tumor biology |
| Q38028791 | The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies |
| Q37518395 | The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications |
| Q38123806 | The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery |
| Q38018809 | The metastatic niche and stromal progression |
| Q36051547 | The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages |
| Q49634844 | The role of macrophage phenotype in regulating the response to radiation therapy |
| Q29614299 | The role of myeloid cells in the promotion of tumour angiogenesis |
| Q33511263 | The role of salvage reirradiation for malignant gliomas that progress on bevacizumab |
| Q37554682 | The role of tumor-associated macrophages in tumor vascularization |
| Q26823489 | The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? |
| Q34444598 | The tumor-immune microenvironment and response to radiation therapy |
| Q48650505 | Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma |
| Q34065630 | Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion |
| Q49544289 | Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer |
| Q33757096 | Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer |
| Q26995733 | Tumor endothelial cells |
| Q38043525 | Tumor endothelial markers as a target in cancer |
| Q42252540 | Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors. |
| Q33829243 | Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells |
| Q37633861 | Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas |
| Q53025231 | Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. |
| Q59799227 | Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6 cancer cell and macrophage polarization |
| Q40219738 | Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors. |
| Q37948053 | Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers |
| Q26999217 | Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy |
| Q42257428 | Vasculogenic cytokines in wound healing |
| Q43170327 | Visualizing anti-tumor immune responses in vivo |
| Q37107054 | miR-155-deficient bone marrow promotes tumor metastasis |
Search more.